Bristol Myers Squibb gets US FDA approval for Opdivo + Yervoy to treat unresectable MPM EP News Bureau Oct 3, 2020 The approval marks the third indication for Opdivo + Yervoy-based treatments in thoracic cancers and seventh indication overall
